JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rössig, L.
Right arrow Articles by Balla, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rössig, L.
Right arrow Articles by Balla, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 36, Issue of September 6, 1996 pp. 22063-22069
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Regulation of Angiotensin II-stimulated Ca2+ Oscillations by Ca2+ Influx Mechanisms in Adrenal Glomerulosa Cells*

(Received for publication, May 8, 1996)

Lothar Rössig , Annamaria Zólyomi , Kevin J. Catt and Tamas Balla Dagger

From the Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

In adrenal glomerulosa cells, angiotensin II (Ang II) evokes repetitive [Ca2+]i transients and increases Ca2+ influx through voltage-sensitive calcium channels (VSCCs) as well as the capacitative Ca2+ entry pathway. This study analyzed the relationships between these Ca2+ influx pathways and intracellular Ca2+ signaling in bovine glomerulosa cells, in which Ca2+ oscillation frequency was regulated by Ang II concentration over the range of 50-300 pM. In the absence of external Ca2+, such oscillations were maintained for prolonged periods of time, but their frequency was significantly reduced (0.23 min-1 versus 0.38 min-1). Restoration of [Ca2+]o to 0.6 mM increased the frequency of Ca2+ oscillations in cells that showed narrow spikes of constant amplitude and caused a plateau response in cells with broad spikes of rapidly decreasing amplitude. In the presence of Ca2+, nifedipine reduced the frequency of the oscillatory Ca2+ response to 100 pM Ang II by 49%, and BAY K 8644 increased oscillation frequency by 86%, or caused plateau-type responses typical of higher Ang II concentrations. In contrast to their prominent actions on Ca2+ spiking frequency, dihydropyridines caused only minor changes in Ang II (100 pM)-induced inositol phosphate production. Dihydropyridines also had minimal effects on the nonoscillatory Ca2+ signals evoked by high Ang II concentrations (10 nM). These findings indicate that Ca2+ influx through VSCCs modulates the frequency of Ca2+ oscillations induced by low agonist concentrations by a mechanism that does not involve major changes in inositol trisphosphate formation. However, VSCCs make relatively little contribution to the nonoscillatory Ca2+ signals generated by high agonist concentrations, when Ca2+ influx occurs predominantly through the capacitative Ca2+ entry pathway.


INTRODUCTION

Repetitive Ca2+ transients occur in a variety of cell types following stimulation with low concentrations of Ca2+-mobilizing agonists. This type of Ca2+ signaling consists of a series of Ca2+ spikes that occur at intervals of 0.5-5 min, depending on the agonist dose and the cell type. Such oscillatory signals, which often persist for 1 h or more, have been observed in cell types ranging from electrically nonexcitable cells such as hepatocytes through partially excitable endocrine and neuroendocrine cells (e.g. pancreatic beta  cells, pituitary cells, and adrenal glomerulosa cells) to classical excitable cells (muscle cells, neurons) (1). In many cases the spiking frequency, rather than the amplitude of the oscillations, is regulated by the agonist concentration, providing the basis of a frequency-encoded Ca2+ signaling mechanism. Although Ca2+ release from internal stores is a major source of the cytoplasmic Ca2+ transients, [Ca2+]i levels are also influenced by Ca2+ entry mechanisms operating through plasma membrane Ca2+ channels. These include a ubiquitous form of Ca2+ influx in which the filling state of the Ca2+ stores regulates Ca2+ influx (``capacitative Ca2+ entry''; see Ref. 2) as well as various types of voltage-sensitive calcium channels (VSCCs)1 that determine Ca2+ influx as a function of the membrane potential in excitable cells.

Recent models to explain the generation of Ca2+ oscillations have focused on the dual regulation of the InsP3 receptor channel by its ambient cytosolic Ca2+ concentrations, with positive and negative feedback by low and high [Ca2+]i, respectively. This mechanism has been proposed to initiate and terminate short bursts of Ca2+ release even at constant InsP3 levels (3, 4, 5). The restoration of basal [Ca2+]i between spikes depends on diverse Ca2+ homeostatic mechanisms, including Ca2+ pumps located in the endoplasmic reticulum (ER) and plasma membrane (6, 7). These processes, and possibly uptake by mitochondria (7, 8, 9, 10), reestablish the resting [Ca2+]i levels and also refill the Ca2+ pools so that a new cycle can be initiated. Due to the high Ca2+ sensitivity of the InsP3 receptor channel, disturbances in the Ca2+ homeostatic mechanism(s) of the cell frequently affect the rate and character of Ca2+ oscillations. For example, the Ca2+ wave frequency in Xenopus oocytes can be accelerated by enhancement of Ca2+ influx (11) as well as by overexpression of a SERCA type Ca2+ pump to promote the rapid resetting of basal [Ca2+]i levels (12). These findings indicate the involvement of both Ca2+ entry and reuptake mechanisms in the regulation of periodic calcium signaling in these large cells. Recent microfluorimetric studies revealed that small microdomains, or so-called hot spots, with little impact on the average [Ca2+]i of the cell may have a crucial role in the regulation of intracellular Ca2+ signaling events (9, 13). This implies that if the Ca2+ stores with their InsP3 receptors and the plasma membrane Ca2+ entry channels are close to one another (14), even small amounts of Ca2+ entering through these channels could be an important factor in the regulation of Ca2+ signals by the local effects of Ca2+ influx.

In the adrenal glomerulosa, the presence of both the capacitative Ca2+ entry pathway (15, 16) and various types of VSCC (17, 18, 19, 20, 21) have been reported. Both of these Ca2+ influx mechanisms are active during Ang II stimulation of bovine glomerulosa cells (15, 22) providing two complementary means to regulate intracellular Ca2+ signaling through Ca2+ entry. Thus, dihydropyridines have been shown to exert minor but consistent effects on the [Ca2+]i plateau following stimulation with high doses of Ang II in suspensions of adrenal zona glomerulosa cells (22, 23, 24). Such results have suggested that voltage-dependent Ca2+ channels make relatively little contribution to the Ca2+ signals generated by Ang II in adrenal cells, which contrasts with the sensitivity of the secretory response of these cells to dihydropyridines, especially at low Ang II concentrations (16). This apparent controversy could be resolved, if the role of VSCC activation is not to increase the overall cytosolic Ca2+ levels but rather to modulate Ca2+ oscillations that occur primarily at lower, more physiological doses (25, 26). To explore the relationship between Ca2+ entry through VSCC and Ca2+ oscillations, we examined the relative contributions of the two Ca2+ entry pathways (VSCC and capacitative Ca2+ influx) to the regulation of periodic Ca2+ release from internal Ca2+ stores in Ang II-stimulated bovine adrenal glomerulosa cells.


EXPERIMENTAL PROCEDURES

Materials

Fura-2/AM, Indo-2/AM, and pluronic acid were purchased from Molecular Probes, Inc. (Eugene, OR). Angiotensin II was purchased from Peninsula Laboratories, Inc. (San Carlos, CA). BAY K 8644, nifedipine, and thapsigargin were obtained from Calbiochem. All other chemicals were from Sigma. Cell culture media were prepared by the NIH Media Unit (Bethesda, MD) or were supplied by Biofluids (Rockville, MD).

Cell Culture

Bovine adrenal zona glomerulosa cells were prepared and cultured as described previously (27). Cells were plated on poly-L-lysine-coated circular coverslips placed in the individual wells of 6-well culture dishes (Corning, NY) at a density of 105 cells/ml (3 ml of cell suspension/well). Cells were cultured for 2-5 days in Dulbecco's modified Eagle's medium supplemented with donor horse serum (10%) and fetal bovine serum (2%) before Ca2+ measurements.

Cytosolic [Ca2+] Measurements

Cells attached to coverslips were loaded with 0.5-5 µM fura-2/AM or indo-1/AM for 2-5 h at room temperature in a modified Krebs-Ringer buffer solution (KRBS) containing 118 mM NaCl, 2.42 mM KCl, 1.8 mM Ca2+, 1.18 mM KH2PO4, 0.8 mM MgSO4, 20 mM Na-Hepes (pH 7.4), 5 mM NaHCO3, 10 mM glucose, and 1 mg/ml bovine serum albumin, supplemented with 0.25% pluronic acid. For [Ca2+]i measurements, the loading buffer was replaced by fresh KRBS or Ca2+-free KRBS. The coverslips were then placed in a 35-mm diameter Teflon culture dish (Medical Systems Corporation, Greenvale, NY), and the [Ca2+]i was determined by microfluorometry using either a single excitation, two emission wavelength procedure with indo-1 (28), or a dual excitation single emission wavelength protocol with fura-2 (29). All stimulations and pharmacological treatments of the cells were performed at room temperature by the addition of the substance diluted in 1 ml of buffer.

Inositol Phosphate Measurements

Inositol phosphates were measured in glomerulosa cells, prelabeled with myo-[3H]inositol (20 µCi/ml) for 24 h, after extraction and separation by high pressure liquid chromatography as described previously (24). Because of the small inositol phosphate response of the cells to 100 pM Ang II, cells were preincubated with LiCl (10 mM) for 30 min and were stimulated with Ang II for 30 min to capture the metabolites of inositol 1,4,5-trisphosphate. Experiments were also performed without lithium, which showed similar results but with smaller changes.

Statistical Analysis

Values are given as mean ± S.E. Analyses of statistical significance were performed using paired or unpaired t tests. For multiple comparisons we used analysis of variance combined with the Duncan test.


RESULTS

Properties of Single Cell [Ca2+]i Responses of Glomerulosa Cells

In bovine adrenal zona glomerulosa cells, stimulation with 100 pM Ang II induced repetitive [Ca2+]i transients with an average frequency of 0.38 ± 0.03 min-1 (n = 40 cells, Fig. 1A). The cytosolic Ca2+ concentration returned to basal levels between individual spikes, which were usually maintained for >1 h with only a slight decrease in amplitude. A 3-fold increase in Ang II concentration caused a significant increase in oscillatory frequency from 0.38 ± 0.05 to 0.63 ± 0.09 min-1 (p < 0.005, n = 5 cells, Fig. 1A) with no major change in spike amplitude. The subsequent addition of 1 nM Ang II elicited a large peak followed by a sustained plateau (Fig. 1B). Direct application of higher concentrations of Ang II (10 nM) usually induced similar biphasic Ca2+ responses with an initial spike followed by a plateau (n = 12, Fig. 1C), but in a subset of cells (35%) it elicited rapid Ca2+ oscillations. This oscillatory signal was preceded by an initial rise in [Ca2+]i with rapid superimposed oscillations of irregular amplitude and an average frequency of 2.07 ± 0.40 min-1 (n = 4, Fig. 1D). These high frequency spikes often merged to resemble the early phase of a sustained plateau response (n = 3, Fig. 1E). After a few such peaks the signal switched to regular base-line spiking with a frequency of 1.36 ± 0.25 min-1 (n = 7, Fig. 1, D and E). The responsiveness of individual cells showed some variation, and plateau elevations in [Ca2+]i were occasionally observed even with 100 pM Ang II. Regular oscillations of very low frequency could be elicited with Ang II concentrations as low as 25 pM, which is within the physiological range of the octapeptide present in the circulation (data not shown).


Fig. 1. Concentration dependence of the [Ca2+]i response to stimulation with Ang II in single bovine adrenal zona glomerulosa cells. A, Ang II (100 pM) induces repetitive Ca2+ transients in the adrenal glomerulosa cell. A 3-fold increase in the agonist concentration causes an increase in the frequency of the Ca2+ oscillation. B, when the concentration of Ang II is raised to 1 nM, the cell responds with a large transient [Ca2+]i increase followed by a sustained plateau. C, a typical ``biphasic'' response consisting of a sharp initial rise in [Ca2+]i followed by a plateau elevation usually occurs after exposure to 10 nM Ang II (65% of all cells tested). Such a plateau phase is not affected by nifedipine. D and E, in about one-third of the cells (35%), Ca2+ oscillations were observed following stimulation with 10 nM Ang II as well. This oscillatory signal is typically of high frequency and is preceded by rapid irregular (D) or merged (E) calcium spikes.
[View Larger Version of this Image (33K GIF file)]

Role of Ca2+ Influx in the Modulation of Ca2+ Oscillations Induced by Low Agonist Concentrations

To study the role of extracellular Ca2+ in the regulation of Ca2+ oscillations, glomerulosa cells were stimulated with 100 pM Ang II in Ca2+-free medium (no added Ca2+). Under these conditions, sustained Ca2+ oscillations were again evident for >1 h in most of the cells. The frequency of these sustained oscillations (but not their amplitude) was significantly lower than that observed in the presence of extracellular Ca2+ (0.23 ± 0.01 min-1, n = 45, p < 0.001).

The addition of 0.6 mM Ca2+ to such Ang II-stimulated cells immediately increased the oscillatory frequency from 0.27 ± 0.02 to 0.52 ± 0.06 min-1 (n = 16 cells, p < 0.001, Fig. 2A). Subsequent increases of [Ca2+]o to 1.2 mM or higher did not cause any further increase in frequency (data not shown). In a subset of cells, addition of extracellular Ca2+ caused an immediate spike followed by a plateau Ca2+ elevation (n = 16, Fig. 2B). Interestingly, such cells showed a pronounced decrease in the amplitude of their Ca2+ transients during stimulation in Ca2+-free medium (Fig. 2B). The average decrease in spike amplitude (19 ± 3% per spike) was significantly higher in this group of cells than in cells that continued to oscillate after the addition of Ca2+ (6 ± 2%, n = 16, p < 0.001, Fig. 3A). The loss of spiking amplitude observed in Ca2+-free medium was positively correlated with the magnitude of the [Ca2+]i rise after the addition of Ca2+ (Fig. 3B, linear fit, p < 0.05). The amplitude of the biphasic [Ca2+]i increase upon addition of Ca2+ also correlated with the average width of the Ca2+ spikes observed in Ca2+-free medium (Fig. 3C, linear fit, p < 0.01), as well as with the interspike interval length (Fig. 3D, linear fit, p < 0.05). The average spike duration was usually significantly higher (101 ± 13 s, n = 16) in cells that responded with a biphasic Ca2+ increase when the [Ca2+]o was increased fom 0 to 0.6 mM than in those that continued to oscillate after the readdition of Ca2+ (34 ± 4 s, n = 16, p < 0.001, Fig. 3A). There was a significant correlation between the average spike duration and the average interspike interval, based on the data from all cells stimulated with 100 pM Ang II in Ca2+-free medium (Fig. 3E, linear fit, p < 0.01). That is, the shorter the Ca2+ spike duration, the more rapid were the oscillations.


Fig. 2. Role of Ca2+ entry in the generation of repetitive Ca2+ transients evoked by 100 pM Ang II. A and B show typical examples of cells that exhibit oscillatory Ca2+ signaling after stimulation with 100 pM Ang II in the absence of extracellular Ca2+. The addition of 0.6 mM [Ca2+]o (while keeping the Ang II concentration constant) leads to an increase in frequency in cells that display narrow Ca2+ transients of stable amplitude (``synchronized'' type (A)). In some cells that show wide spikes with rapidly decreasing amplitudes, Ca2+ addition leads to a plateau type of response (``non-synchronized'' (B)), similar to the effects of increasing agonist doses (see Fig. 1B). The addition of nifedipine partially reverses the frequency increase in A (see also Table II). However, once a plateau is reached nifedipine is unable to restore base-line spiking (B), suggesting the dominance of the capacitative non-DHP-sensitive component in this type of response. A low concentration of thapsigargin (20 nM) causes a transient increase in frequency, with loss of spike amplitude and widening of the Ca2+ spikes before the oscillations cease. The addition of extracellular Ca2+ in such thapsigargin-treated cells always leads to a relatively low biphasic rise in [Ca2+]i (C).
[View Larger Version of this Image (18K GIF file)]


Fig. 3. Correlation between Ca2+ oscillatory parameters in Ca2+-free medium and the type of Ca2+ response to the addition of extracellular Ca2+. A, adrenal glomerulosa cells that were stimulated with 100 pM Ang II in Ca2+-free medium responded to the addition of 0.6 mM Ca2+ either with a frequency increase or with a biphasic Ca2+ response. Cells that responded with increased frequency had significantly shorter spike duration and little loss of spike amplitude before the Ca2+ addition, while the biphasic Ca2+ response was characteristic of cells that had longer spike duration and rapid loss of amplitude in Ca2+-free medium. Thapsigargin (20 nM) was able to increase spike duration and caused pronounced loss of spike amplitude, thereby mimicking the pattern of the cells showing biphasic response. Panels B-D, correlations between oscillatory parameters observed in Ca2+-free medium and the [Ca2+]i rise detected after Ca2+ addition in cells showing biphasic [Ca2+]i responses after restoring external Ca2+ (p < 0.05 (B); p < 0.01 (C); p < 0.05 (D)). E, correlation between spike duration and oscillatory frequency in cells stimulated with 100 pM Ang II in Ca2+-free medium (n = 45, p < 0.01).
[View Larger Version of this Image (33K GIF file)]

Effect of Thapsigargin on Ang II-induced Ca2+ Oscillations

The above correlation between the average duration of [Ca2+]i spikes and the oscillatory frequency was relevant to recent observations in Xenopus laevis oocytes, in which overexpression of a SERCA Ca-ATPase caused an increase in the frequency of InsP3-induced [Ca2+]i waves and a decrease in the average wave duration (12). The effect of changes in SERCA Ca2+-ATPase activity on Ca2+ oscillations in glomerulosa cells during stimulation with 100 pM Ang II in Ca2+-free medium was evaluated by treatment with low concentrations of the microsomal Ca2+-ATPase inhibitor, thapsigargin. The impairment of Ca2+ sequestering ability caused by the addition of 20 nM thapsigargin to cells exhibiting narrow Ca2+ spikes caused an increase in spike duration and a more rapid loss of amplitude (Fig. 2C). This effect resembled the oscillatory pattern of cells that responded with biphasic Ca2+ increases after the addition of Ca2+ (Fig. 3A and Table I). Such thapsigargin-treated cells always displayed a biphasic rise in [Ca2+]i upon addition of 0.6 mM [Ca2+]o and never continued to oscillate (n = 13, Fig. 2C). However, it should be noted that the mean amplitude of the rise in [Ca2+]i in response to extracellular Ca2+ was significantly smaller than in cells in which a biphasic [Ca2+]i rise in response to extracellular Ca2+ occurred in the absence of thapsigargin (Table I). Thapsigargin also caused a transient increase of spiking frequency before slowing and eventually terminating the oscillatory Ca2+ signal (Fig. 2C and Table I).

Table I.

Ca2+ oscillations elicited by low (100 pM) and high (10 nM) concentrations of Ang II in Ca2+-free medium

Single glomerulosa cells were stimulated in Ca2+-free medium with the indicated concentrations of Ang II. Once an oscillatory [Ca2+]i signal had been established, 0.6 mM [Ca2+]o was added to the medium. At both Ang II concentrations, two types of responses were observed upon addition of extracellular Ca2+ ions. Cells stimulated with 100 pM Ang II displayed either an acceleration in their oscillatory frequency or a biphasic [Ca2+]i increase. Treatment of cells that belonged to the former group with thapsigargin (20 nM) caused a change to an oscillatory pattern that was characteristic of the latter group and also made these cells to respond with biphasic [Ca2+]i increase after Ca2+ addition. Ca2+ oscillations driven by 10 nM Ang II either were independent of extracellular Ca2+ or showed a biphasic rise in [Ca2+]i. The latter group was similar in its parameters to the cells that responded with a biphasic Ca2+ increase upon addition of Ca2+ after stimulation with 100 pM Ang II. The former group, however, resembled in its spike parameters the one that was stimulated by 100 pM Ang II and was accelerated by external Ca2+]. (*, p < 0.01; **, p < 0.001; ***, p < 0.001 compared with the amplitude observed in the absence of thapsigargin).
100 pM Ang II
10 nM Ang II
Acceleration of spiking frequency (n = 16) Biphasic increase (n = 16) Thapsigargin (20 nM)
Oscillations independent of Ca2+ (n = 5) Biphasic increase (n = 8)
Before After

Average frequency during Ca2+-free period (min-1) 0.27  ± 0.02 0.21  ± 0.02 0.22  ± 0.02 0.34  ± 0.03** 1.00  ± 0.14 0.28  ± 0.05
Average spike duration before Ca2+ addition (s) 34  ± 4 101  ± 13 50  ± 5 86  ± 13* 35  ± 5 85  ± 11
Loss of amplitude per spike (% of the preceding spike) 6  ± 2 19  ± 3 10  ± 1 36  ± 5** 5  ± 1 23  ± 3
[Ca2+]i rise upon Ca2+ addition (triangle  ratio) NA 0.52  ± 0.06 0.23  ± 0.02*** NAa 0.61  ± 0.10
Acceleration in spiking frequency (%) +85 NA NA  -6 NA

a  NA, not applicable.

Involvement of Ca2+ Entry in the Generation of [Ca2+]i Responses to High Concentrations of Ang II

To study the role of extracellular Ca2+ during stimulation with high Ang II concentrations, glomerulosa cells were treated with 10 nM Ang II in Ca2+-free medium (no added Ca2+, without EGTA). This hormone concentration usually caused a biphasic [Ca2+]i increase when added in the presence of Ca2+ (Fig. 1C). However, under Ca2+-free conditions 10 nM Ang II evoked Ca2+ oscillations, although of a different character than those elicited by 100 pM Ang II (Fig. 4 and Table I). Such responses were typically large and rapid Ca2+ elevations in which the individual spikes were superimposed and showed a progressive decrease in amplitude. This initial phase was usually followed by base-line oscillations of higher frequency and of variable amplitude and spike duration, depending on the individual cell. The responses of these cells to the addition of Ca2+ could be classified as follows. In about 30% of the cells (5 of 15) in which the Ang II-evoked signal stabilized as regular oscillations of high amplitude, narrow spike duration, and high frequency, the response was unaffected by extracellular Ca2+ (Fig. 4A), being 1.00 ± 0.14 and 0.94 ± 0.14 min-1 in the absence and presence of 0.6 mM [Ca2+]o, respectively. In a second group of cells (8 of 15) that showed wide, low frequency spikes of greatly diminished amplitude, the addition of Ca2+ caused a biphasic [Ca2+]i increase (Fig. 4C). The remaining two cells showed an ``intermediate'' response in that the addition of 0.6 mM Ca2+ caused a transient run of high frequency oscillations with an elevated interspike [Ca2+]-level, followed by a return to high frequency base-line oscillations (Fig. 4B).


Fig. 4. Effect of extracellular Ca2+ on Ca2+ signaling induced by high concentration of Ang II (10 nM). Glomerulosa cells stimulated with 10 nM Ang II in Ca2+-free medium displayed two typical types of Ca2+ oscillations: one with high frequency that was not affected by the addition of extracellular Ca2+ (A; also compare with Fig. 1, D and E) and another with a rapid rise in [Ca2+]i in response to 0.6 mM [Ca2+]o followed by a nonoscillatory plateau (C; see also Fig. 1C). In a few cells, the oscillatory signal was maintained at higher frequency after the admission of extracellular Ca2+ (B).
[View Larger Version of this Image (16K GIF file)]

Effects of Dihydropyridines on Ang II-induced Ca2+ Oscillations

The contribution of VSCCs to the regulation of Ca2+ oscillations was examined in Ang II-stimulated cells treated with dihydropyridine agonist (BAY K 8644) and antagonist (nifedipine) derivatives. As shown in Fig. 5A, BAY K 8644 (10 nM) significantly increased the frequency of Ang II (100 pM)-induced Ca2+ oscillations (in 7 of 13 cells) by 86% from 0.43 ± 0.08 to 0.80 ± 0.18 min-1 (p < 0.02) or changed the oscillatory Ca2+ signal to a plateau type response (in 6 of 13 cells, Fig. 5B). Conversely, nifedipine (2 µM) significantly decreased the frequency of Ca2+ oscillations by 49% from 0.76 ± 0.08 to 0.39 ± 0.05 min-1 (p < 0.02, n = 6 out of 6 cells, Fig. 5C). In an additional subset of cells that exhibited Ca2+ plateaus even at low Ang II concentrations, these were converted by nifedipine to regular repetitive Ca2+ transients (n = 7 cells, Fig. 5D). In contrast, the plateau components of biphasic Ca2+ responses elicited by high Ang II concentrations (10 nM) were not significantly affected by either nifedipine (Fig. 1C) or BAY K 8644 (not shown). In the few cells that displayed spontaneous [Ca2+]i signals in the absence of any stimulus (in the form of elevated, noisy base lines), these were terminated by treatment with nifedipine (Fig. 5E), suggesting their dependence on Ca2+ entry through VSCCs. The reciprocal effects of BAY K 8644 and nifedipine on [Ca2+]i signaling following stimulation with a high [K+]o (30 mM) to activate VSCCs in glomerulosa cells are shown in Fig. 5F.


Fig. 5. Regulation of Ang II-induced Ca2+ oscillations by dihydropyridines. Adrenal glomerulosa cells were stimulated with 100 pM Ang II in normal Ca2+ medium to evoke Ca2+ oscillations. The addition of BAY K 8644 (10 nM) results in an increase in the frequency of the transients (A) or shifts the oscillatory signal to a sustained [Ca2+]i plateau (B). C, nifedipine (2 µM) reduces the oscillatory frequency. D, highly responsive cells that displayed a plateau-type signal in response to 100 pM Ang II were returned to regular oscillations by nifedipine. E, spontaneous irregular elevations in [Ca2+]i in the absence of agonist occurred in a small subset of glomerulosa cells and were sensitive to nifedipine. F, the effects of BAY K 8644 and nifedipine on the extracellular K+ (30 mM)-induced [Ca2+]i response in single bovine adrenal ZG cells are shown for comparison with those elicited by Ang II.
[View Larger Version of this Image (35K GIF file)]

Contribution of VSCC to Regulation of Ca2+ Oscillations by Extracellular Ca2+

To estimate the extent to which Ca2+ influx through VSCC contributes to the rise in frequency caused by increases in extracellular Ca2+ concentration, nifedipine (2 µM) was added after the restoration of [Ca2+]o in Ang II (100 pM)-stimulated cells (Fig. 2A). Comparison of the oscillatory frequencies observed before and after Ca2+ addition and after administration of nifedipine in the presence of external Ca2+, gives an index of the VSCC component of extracellular Ca2+-dependent frequency modulation. Such comparison was achieved by expressing the oscillation frequency as a percentage of that observed in the presence of Ca2+ after Ca2+ restoration. This analysis showed that while the frequency was decreased by 30% after administration of nifedipine in the Ca2+-restored state it was still significantly higher than that recorded before Ca2+ addition (50%, n = 6 cells; Fig. 2A and Table II). Nifedipine (2 µM) had no effect on the plateau level of [Ca2+]i when the same experimental protocol was used with a high dose (10 nM) of Ang II (not shown).

Table II.

DHP-sensitive component of extracellular Ca2+-mediated regulation of Ang II-induced Ca2+ oscillations

Comparison of the intertransient intervals (mean ± S.E.) in six individual bovine adrenal glomerulosa cells following stimulation with 100 pM Ang II in Ca2+-free medium, before, and after the addition of 0.6 mM [Ca2+]o and following the subsequent addition of nifedipine (2 µM). The frequencies are expressed as percentage of that observed in 0.6 mM [Ca2+]o-containing medium (control, 100%). Statistical significance was calculated by analysis of variance with the Duncan test (*, p < 0.005 compared with 0.6 mM [Ca2+]o; **, p < 0.005 compared with 0.6 mM [Ca2+]o and p < 0.05 compared with Ca2+-free, F, nifedipine-sensitive part of the Ca2+-dependent frequency enhancement as percentage of the entire frequency increase; n, number of intervals counted in each trace.
Cell Ca2+-free
0.6 mM [Ca2+]o
Nifedipine (2 µM)
n min-1 % s n min-1 % s n min-1 % s F

1 5 0.46 31 131  ± 6 10 1.5 100 40  ± 1 10 0.54 36 112  ± 2 92
2 3 0.18 38 341  ± 5 6 0.48 100 126  ± 4 5 0.41 85 148  ± 11 23
3 5 0.29 67 208  ± 45 6 0.43 100 138  ± 5 7 0.36 84 169  ± 19 50
4 4 0.23 72 256  ± 17 4 0.32 100 188  ± 6 4 0.24 75 250  ± 6 89
5 5 0.28 43 217  ± 11 8 0.65 100 93  ± 6 7 0.48 74 126  ± 6 46
6 4 0.23 45 262  ± 24 7 0.51 100 117  ± 5 6 0.34 67 175  ± 8 61
Mean ± S.E. of six cells 0.28  ± 0.04 49  ± 7 236  ± 28 0.65  ± 0.18 100  117  ± 20 0.40  ± 0.04 70  ± 7    163  ± 20** 60  ± 11

Effect of Dihydropyridines on Inositol Phosphate Formation

Since Ca2+ influx has been shown to affect InsP3 formation in agonist-stimulated cells (24, 30, 31), we determined whether the effects of dihydropyridines on Ca2+ signaling were due to the increased formation of this second messenger. Glomerulosa cells prelabeled with myo-[3H]inositol were stimulated with low concentrations (100 or 300 pM) of Ang II in the presence of 10 mM Li+ to quantitate the small amount of InsP3 (mostly in the form of its metabolites) that is produced under these conditions. The effects of the dihydropyridines on inositol phosphate responses to 100 pM Ang II were negligible compared with the prominent response elicited by raising the Ang II concentration from 100 pM to 300 pM (Fig. 6). Since the addition of BAY K 8644 and elevation of Ang II concentration from 100 to 300 pM caused a comparable increase in Ca2+ oscillatory frequency (86 and 75% increases, respectively), these results indicated that the effects of dihydropyridines on Ca2+ oscillations are not attributable to changes in InsP3 production.


Fig. 6. Effects of dihydropyridines on the accumulation of inositol phosphates in glomerulosa cells stimulated with 100 pM Ang II. Bovine adrenal glomerulosa cells prelabeled with [3H]inositol were preincubated with 10 mM Li+ for 30 min before stimulation with 100 pM or 300 pM Ang II for 30 min. Nifedipine (2 µM), BAY K (10 nM), or medium were added after 8 min of stimulation by 100 pM Ang II. Results are presented as mean ± S.E. of three or four individual experiments, each performed in duplicate. Similar but smaller changes were observed in the absence of Li+ (data not shown).
[View Larger Version of this Image (22K GIF file)]


DISCUSSION

The characteristics of the oscillatory Ca2+ responses of adrenal glomerulosa cells to low doses of Ang II were similar to those of the ``base line-spiking'' Ca2+ oscillations first described in single hepatocytes (32). These oscillations consisted of Ca2+ transients separated by long interspike base-line intervals and showed frequency modulation at low agonist concentrations. Higher concentrations of Ang II usually evoked nonoscillatory signals that consisted of a rapid rise to a peak [Ca2+]i followed by a fall to a lower plateau elevation (``biphasic response''). The rapid initial [Ca2+]i increase appeared to consist of superimposed Ca2+ transients that sometimes could be resolved into partially separated spikes. Individual Ca2+ responses showed a degree of heterogeneity, and in many cases low agonist doses initiated regular oscillations that subsequently changed to nonoscillatory plateau increases. Conversely, a small number of cells responded to high dose Ang II stimulation with high frequency oscillations that were maintained for a prolonged period of time.

The basic mechanism of the oscillations observed in cells stimulated by Ca2+-mobilizing hormones is dependent on the InsP3-gated Ca2+ release from intracellular stores through the InsP3 receptor-Ca2+ channel, and its subsequent reuptake into the same stores. The periodicity of Ca2+ release at any given InsP3 concentration is believed to result from the rapid stimulatory and slower inhibitory effects of small and large [Ca2+]i increases, respectively, on the activity of the InsP3 receptor channel (3, 33). Accordingly, in addition to agonist-induced increases in intracellular InsP3 concentration, changes in [Ca2+]i have a major impact on the character of Ca2+ oscillations. Theoretically, InsP3-induced oscillations can be maintained in a closed system in which there is no net movement of Ca2+ through the plasma membrane and only the periodic emptying and refilling of the intracellular Ca2+ stores contributes to the cytosolic Ca2+ changes (34). However, in real cells the plasma membrane Ca2+ pumps and the various Ca2+ influx mechanisms make major contributions to the changes in [Ca2+]i. It was previously assumed that the activation of voltage-sensitive Ca2+ influx mechanism(s) by periodic depolarization (action potentials), as well as capacitative Ca2+ entry pathways activated by the depletion of intracellular Ca2+ stores, cause significant increases in [Ca2+]i. However, recent data suggest that under physiological conditions such Ca2+ influx can modulate Ca2+ release from internal stores without necessarily changing the average cytosolic Ca2+ concentration (11). This concept posits that the limited amount of Ca2+ that enters the cell during agonist stimulation does not cause a measurable increase in [Ca2+]i but rather a local elevation that influences the Ca2+ release process by acting specifically at the Ca2+-regulatory site of the InsP3 receptor.

The results of the present study clearly demonstrate that Ca2+ influx regulates the frequency of Ca2+ oscillations in adrenal glomerulosa cells stimulated by low agonist concentrations. Similar findings have been recently reported in the exocrine avian nasal gland and in HeLa cells (35, 36). However, in glomerulosa cells, nifedipine and BAY K 8644 had a pronounced effect on Ca2+ oscillations, suggesting that the extracellular Ca2+-dependent frequency modulation involves dihydropyridine-sensitive VSCCs. Furthermore, the increased oscillatory frequency caused by the addition of Ca2+ was not usually accompanied by a significant increase in base-line [Ca2+]i, indicating that the amount of Ca2+ entering the cells did not cause an overall increase in the cytosolic Ca2+ concentration. Rather, such Ca2+ influx changed the sensitivity of the InsP3-dependent triggering process that determines the oscillation frequency. Such a change could result from either an increase in the InsP3 concentration caused by Ca2+ influx (24, 31) or local increases of Ca2+ at the microdomains adjacent to the Ca2+-regulatory site of the InsP3-receptor/Ca2+ channel (3).

Studies in [3H]inositol-labeled glomerulosa cells indicated that the frequency modulation caused by dihydropyridines was not accompanied by corresponding changes in InsP3 production. In cells stimulated with 100 pM Ang II, the addition of BAY K 8644 caused a similar frequency increase as elevation of the Ang II concentration to 300 pM but had no significant effect on inositol phosphate production. These findings suggest that changes in Ca2+ concentration due to increased Ca2+ influx have an important regulatory function at the level of the InsP3 receptor. In this regard, it is interesting to note that a significant negative correlation exists between the duration of Ca2+ spikes and the interspike intervals in cells stimulated with low Ang II concentrations in Ca2+-free medium, so that relatively narrow spikes were accompanied by higher spiking frequency. Since cells that show these narrow spikes do not appear to lose significant amounts of Ca2+ during oscillations, this observation indicates that the activity of the SERCA Ca2+ pump is an important determinant of the refractory period. This finding is in agreement with recent data obtained in X. laevis oocytes, in which overexpression of a SERCA Ca2+ pump caused synchronization and increased frequency of oscillations (12).

While regular oscillations were characteristic of most glomerulosa cells stimulated with low agonist concentrations, these usually changed to sustained [Ca2+]i elevations at higher agonist doses, and in some cases even at low Ang II concentrations. Such nonoscillatory Ca2+ responses appeared to be a characteristic of cells in which the intracellular Ca2+ pools are unable to completely refill, with consequently more active capacitative Ca2+ influx pathways. This is clearly the case when cells are stimulated with high Ang II concentrations in the presence of Ca2+, where the high levels of InsP3 prevent pool refilling. Cells exposed to high concentrations of Ang II are still able to oscillate in Ca2+-deficient medium, partly due to a smaller InsP3 increase (24) and a lesser Ca2+ load in the cytosol due to the lack of Ca2+ influx. A similar extracellular Ca2+-dependent switch from oscillatory to nonoscillatory response was seen in some cells stimulated at low Ang II concentration after the addition of dihydropyridines. Thus, the addition of BAY K 8644 sometimes converted the oscillatory response to a sustained plateau, while nifedipine reestablished regular oscillations in cells that showed sustained [Ca2+]i increases.

The heterogeneity of the [Ca2+]i responses to the addition of external Ca2+ in Ang II-stimulated cells also shed some light on the conditions under which Ca2+ oscillations are not maintained in the presence of Ca2+. Thus, the biphasic Ca2+ increase with no oscillations was a characteristic response to Ca2+ addition of cells that showed broad spikes and/or rapidly decreasing spike amplitudes when stimulated with Ang II in Ca2+-free medium. On the other hand, cells with narrow and regular spikes responded to the addition of Ca2+ with an increase in oscillatory frequency but could behave like the former cells after minor inhibition of their SERCA Ca2+ pump by thapsigargin. These observations also implicate the Ca2+ reuptake mechanism(s), and its ability to restore basal Ca2+ levels and refill the Ca2+ pools, as a major prerequisite for the maintenance of regular oscillations in the presence of Ca2+. Under conditions of pool depletion, the major form of Ca2+ entry is the capacitative Ca2+ influx pathway, as evidenced by the large capacitative refilling event observed in such cells after the readdition of Ca2+. The minor effects of dihydropyridines on the sustained [Ca2+]i elevations in these cells are consistent with the notion that the amount of Ca2+ entering through VSCCs during Ang II stimulation is not sufficient to produce a major increase of the average cytosolic Ca2+ level.

In summary, the present study demonstrates that in adrenal glomerulosa cells stimulated by low Ang II concentrations, Ca2+ entry through VSCCs acts as a major regulator of the cytosolic Ca2+ response, primarily by modifying the characteristics of the Ca2+ oscillations. At higher agonist concentrations, or when intracellular Ca2+ pools are subject to depletion, the capacitative entry pathway, which is a major contributor to the plateau increase of [Ca2+]i, is activated with no further oscillations. Local changes in the Ca2+ concentration at the Ca2+-regulatory site of the InsP3 receptor Ca2+ channel probably represent the mechanism through which extracellular Ca2+ affects Ca2+ oscillations.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Endocrinology and Reproduction Research Branch, National Institutes of Health, Bldg. 49, Rm. 6A36, 9000 Rockville Pike, Bethesda, MD 20892. Tel.: 301-496-2136; Fax: 301-480-8010.
1   The abbreviations used are: VSCC, voltage-sensitive calcium channels; InsP3, inositol 1,4,5-trisphosphate; ER, endoplasmic reticulum; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; Ang II, angiotensin II; DHP, dihydropyridine(s); KRBS, Krebs-Ringer buffer solution.

REFERENCES

  1. Berridge, M. J. (1990) J. Biol. Chem. 265, 9583-9586 [Free Full Text]
  2. Putney, J. W., Jr., Bird, G., St, J. (1994) Trends Endocrinol. Metab. 5, 256-260 [Medline] [Order article via Infotrieve]
  3. Bezprozvanny, I., Watras, J., Ehrlich, B. E. (1991) Nature 351, 751-754 [CrossRef][Medline] [Order article via Infotrieve]
  4. Iino, M., Endo, M. (1992) Nature 360, 76-78 [CrossRef][Medline] [Order article via Infotrieve]
  5. Stojilkovic, S. S., Kukuljan, M., Tomic, M., Rojas, E., Catt, K. J. (1993) J. Biol. Chem. 268, 7713-7720 [Abstract/Free Full Text]
  6. Tepikin, A. V., Voronina, S. G., Gallacher, D. V., Petersen, O. H. (1992) J. Biol. Chem. 267, 14073-14076 [Abstract/Free Full Text]
  7. Pozzan, T., Rizzuto, R., Volpe, P., Meldolesi, J. (1994) Physiol. Rev. 74, 595-636 [Free Full Text]
  8. Bird, G., St, J., Obie, J. F., Putney, J. W., Jr. (1992) J. Biol. Chem. 267, 18382-18386 [Abstract/Free Full Text]
  9. Rizzuto, R., Brini, M., Murgia, M., Pozzan, T. (1993) Science 262, 744-747 [Abstract/Free Full Text]
  10. Jouaville, L. S., Ichas, F., Holmuhamedov, E. L., Camacho, P., Lechleiter, J. D. (1995) Nature 377, 438-441 [CrossRef][Medline] [Order article via Infotrieve]
  11. Girard, S., Clapham, D. (1993) Science 260, 229-232 [Abstract/Free Full Text]
  12. Camacho, P., Lechleiter, J. D. (1993) Science 260, 226-229 [Abstract/Free Full Text]
  13. Clapham, D. E. (1995) Cell 80, 259-268 [CrossRef][Medline] [Order article via Infotrieve]
  14. Allbritton, N. L., Meyer, T., Stryer, L. (1992) Science 258, 1812-1815 [Abstract/Free Full Text]
  15. Ely, J. A., Ambroz, C., Baukal, A. J., Christensen, S. B., Balla, T., Catt, K. J. (1991) J. Biol. Chem. 266, 18635-18641 [Abstract/Free Full Text]
  16. Burnay, M. M., Python, C. P., Vallotton, M. B., Capponi, A. M., Rossier, M. F. (1994) Endocrinology 135, 751-758 [Abstract]
  17. Matsunaga, H., Yamashita, N., Maruyama, Y., Kojima, I., Kurokawa, K. (1987) Biochem. Biophys. Res. Commun. 149, 1049-1054 [CrossRef][Medline] [Order article via Infotrieve]
  18. Durroux, T., Gallo-Payet, N., Payet, M. D. (1988) J. Physiol. 404, 713-729 [Abstract/Free Full Text]
  19. Cohen, C. J., McCarthy, R. T., Barrett, P. Q., Rasmussen, H. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2412-2416 [Abstract/Free Full Text]
  20. McCarthy, R. T., Isales, C., Rasmussen, H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3260-3264 [Abstract/Free Full Text]
  21. Rossier, M. F., Aptel, H. B. C., Python, C. P., Burnay, M. M., Vallotton, M. B., Capponi, A. M. (1995) J. Biol. Chem. 270, 15137-15142 [Abstract/Free Full Text]
  22. Ambroz, C., Catt, K. J. (1992) Endocrinology 131, 408-414 [Abstract]
  23. Capponi, A. M., Lew, P. D., Jornot, L., Vallotton, M. B. (1984) J. Biol. Chem. 259, 8863-8869 [Abstract/Free Full Text]
  24. Balla, T., Nakanishi, S., Catt, K. J. (1994) J. Biol. Chem. 269, 16101-16107 [Abstract/Free Full Text]
  25. Quinn, S. J., Williams, G. H., Tillotson, D. L. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5754-5758 [Abstract/Free Full Text]
  26. Johnson, E. I. M., Capponi, A. M., Vallotton, M. B. (1989) J. Endocrinol. 122, 391-402 [Abstract]
  27. Guillemette, G., Baukal, A. J., Balla, T., Catt, K. J. (1987) Biochem. Biophys. Res. Commun. 142, 15-22 [CrossRef][Medline] [Order article via Infotrieve]
  28. Stojilkovic, S. S., Merelli, F., Iida, T., Krsmanovic, L. Z., Catt, K. J. (1990) Science. 248, 1663-1666 [Abstract/Free Full Text]
  29. Tomic, M., Dufau, M. L., Catt, K. J., Stojilkovic, S. S. (1995) Endocrinology 136, 3422-3429 [Abstract]
  30. Harootunian, A. T., Kao, J. P., Tsien, R. Y. (1991) Science 251, 75-78 [Abstract/Free Full Text]
  31. Renard, D. C., Poggioli, J., Berthon, B., Claret, M. (1987) Biochem. J. 243, 391-398 [Medline] [Order article via Infotrieve]
  32. Woods, N. M., Cuthbertson, K. S. R., Cobbold, P. H. (1986) Nature 319, 600-602 [CrossRef][Medline] [Order article via Infotrieve]
  33. Iino, M. (1990) J. Gen. Physiol. 95, 1103-1122 [Abstract/Free Full Text]
  34. Keizer, J., Li, Y.-X., Stojilkovic, S. S., Rinzel, J. (1995) Mol. Biol. Cell 6, 945-951 [Abstract]
  35. Shuttleworth, T. J., Thompson, J. L. (1996) Biochem. J. 313, 815-819
  36. Bootman, M. D., Young, K. W., Young, J. M., Moreton, R. B., Berridge, M. J. (1996) Biochem. J. 314, 347-354

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
H McNeill, E Whitworth, G P Vinson, and J P Hinson
Distribution of extracellular signal-regulated protein kinases 1 and 2 in the rat adrenal and their activation by angiotensin II
J. Endocrinol., October 1, 2005; 187(1): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Aguirre, F. C. L. Jayes, and J. D. Veldhuis
Luteinizing Hormone (LH) Drives Diverse Intracellular Calcium Second Messenger Signals in Isolated Porcine Ovarian Thecal Cells: Preferential Recruitment of Intracellular Ca2+ Oscillatory Cells by Higher Concentrations of LH
Endocrinology, June 1, 2000; 141(6): 2220 - 2228.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Yamazaki, T. Kimoto, K. Higuchi, Y. Ohta, S. Kawato, and S. Kominami
Calcium Ion as a Second Messenger for o-Nitrophenylsulfenyl-Adrenocorticotropin (NPS-ACTH) and ACTH in Bovine Adrenal Steroidogenesis
Endocrinology, December 1, 1998; 139(12): 4765 - 4771.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rössig, L.
Right arrow Articles by Balla, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rössig, L.
Right arrow Articles by Balla, T.